Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: dyazide / prozac / nsaids / inderal / cefazolin attending: chief complaint: mssa bacteremia major surgical or invasive procedure: ej placement hemodialysis history of present illness: hpi: 65f w/ mmp including dm2, cad, chf, s/p cva, esrd s/p transplant still on hd (mwf) s/p admission for nausea/vomiting after lue angioplasty for stenosis in her hd fistula, found to have wbc 19 with 5% bands. however, 2 subsequent cbcs showed normal wbc with no bands. patient without fever or localizing symptoms, so d/ced home . nightfloat was called when blood cultures grew out gpc in pairs and clusters. pt was then called and asked to return to the ed for iv abx admission. . in the ed, afebrile. vss. given 1g of vancomycin. pt then developed itching in her r.arm after infusion of vanco. she did not develop skin rash/hives/wheezing or sob. she was given a dose of benedryl. . pt currents states that she feels "jumpy", "sleepy", and that her stomach is "edgy". however, she denies fevers/chills, ha/lh/dizziness, uri symptoms, sob/cp/palp, abd pain/n/v/d/c/melena/brbpr, dysuria/hematuria, joint pains or skin rash. . past medical history: -esrd s/p cadaveric renal transplant in back on hd at m-w-f. (continues on prednisone). post transplant course c/b c.dif infection, polyoma virus infection -dm ii with retinopathy, neuropathy, neuropathy -hyperlipidemia -hypertension -s/p mult cva's (recently ) -chf diastolic function-last echo . mild -cad s/p cath -lad 50% stenosed; 2 vessel cad -pulmonary artery hypertension -s/p cataract extraction -pna treated at in -s/p thrombectomy lue graft -hyperparathyroidism -l2 compression fracture -depression -anemia social history: lives with daughter. retired nurses aid. no tobacco or etoh use. walks with cane for balance. born in . hd at m/w/f. family history: father w/ dm and kidney disease and mother w/ htn physical exam: physical exam: vitals - t98.5, bp 138/42, hr 58, rr 24, sat 100% ra, wt 76.8kg general: lying in bed, appears stated age, nad skin: no rashes, no hives, palpable thrill in l av fistula heent: nc/at, perrla, eomi, anicteric cardiac: s1s2 rrr +4/6 systolic murmur loudest in rusb. no r/g lung: b/l ae no w/c/r abdomen: +bs, soft, nt, nd ext: no c/c/e 2+pulses neuro: aaox2 (did not know date), cn ii-xii intact pertinent results: blood culture, routine (final ): staph aureus coag +. final sensitivities. please contact the microbiology laboratory () immediately if sensitivity to clindamycin is required on this patient's isolate. sulfa x trimeth sensitivity testing confirmed by . sensitivities: mic expressed in mcg/ml _________________________________________________________ staph aureus coag + | erythromycin---------- =>8 r gentamicin------------ <=0.5 s levofloxacin---------- 4 r oxacillin------------- 0.5 s penicillin g---------- =>0.5 r trimethoprim/sulfa---- =>320 r anaerobic bottle gram stain (final ): reported by phone to dr at 1:30 on . gram positive cocci in pairs and clusters. 11:20am lactate-1.4 11:15am glucose-118* urea n-52* creat-5.9* sodium-143 potassium-4.5 chloride-99 total co2-31 anion gap-18 11:15am wbc-9.5 rbc-4.67 hgb-13.2 hct-41.8 mcv-89 mch-28.3 mchc-31.6 rdw-14.6 11:15am neuts-77.8* lymphs-13.5* monos-5.0 eos-3.4 basos-0.3 09:40am alt(sgpt)-19 ast(sgot)-23 ck(cpk)-121 alk phos-120* amylase-198* tot bili-0.4 - ekg probable ectopic atrial rhythm. borderline right axis deviation with modest right ventricular conduction delay. diffuse non-specific t wave flattening. compared to the previous tracing of ectopic atrial rhythm is new. . imaging: echo - impression: no definite evidence of endocarditis in the setting of structurally thickened valves. moderate symmetric left ventricular hypertrophy with preserved global and regional biventricular systolic function. diastolic dysfunction. mild resting left ventricular outflow tract obstruction. mild aortic stenosis. moderate aortic regurgitation. mild mitral regurgitation. compared with the prior report (images unavailable for review) of , the lvot gradient has decreased. aortic regurgitation has increased. ct impression: 1. no evidence of intra-abdominal or intrapelvic source of infection. 2. cholelithiasis without evidence of cholecystitis. 3. sub-4-mm pleural-based pulmonary nodules in the right lower lobe. . ultrasound right arm - findings consistent with a predominantly thrombosed pseudoaneurysm of the mid graft as above. . - tagged wbc scan - impression: no abnormal foci of tracer uptake. brief hospital course: impression and plan: 65 yo f w/ mmp incld esrd s/p renal tx. on hd (mwf), dm, chf, cad presents 1 day after discharge after having been found to have +mssa blood cultures. now on cefazolin dosed at dialysis and is s/p cefazolin desensitization in the micu. 1. bacteremia - blood cultures negative since ; requires total of 6 weeks of antibiotics - prior antibiotics vanco , x1 nafcillin , cefazolin 1g iv with hd (1.5g on fridays) (- - as of - on cefazolin so that it can be dosed at dialysis as outpatient: final id recs are cefazolin 1 gram m/w and 1.5 gram on frdiay - tagged wbc scan today without specific foci of uptake - ct of abdomen with contrast showed no acute or infectious process. -tee not tolerated by patient and will not be further pursued (would require general anesthesia)so cannot rule out bacterial endocarditis as potential source therefore will treat for full course 6 weeks - pt will not need graft removed as tagged wbc scan does not show evidence of overwhelming uptake in that region - history of cefazolin allergy s/p desensitization, had + swelling over left eye concerning for reaction , however swelling has improved and patient has received furthur dosing today. - if pt tolerates antibiotic today would consider d/c tomorrow, will require home visiting nurses services - also if stable tomorrow, can remove ej before discharge 2. esrd: the patient is s/p cadaveric renal transplant in back on hd. -on tacrolimus, bactrim ds, prednisone, nephrocaps, and cinacalcet, continue dialysis . 3. type 2 diabetes: -pt sometimes hypoglycemic after dialysis. -pt frequently hypoglycemic during this hospital stay, holding half of nph dose . 4. chronic diastolic chf: - currently euvolemic, fluid management as per dialysis, continue acei/bb, on , statin, b-blocker . 5. cad: continue on , statin, beta-blocker, ace-i. 6. hypercholesterolemia: continue statin. 7. anemia of chronic kidney disease: h/h is 11/34 -continue epogen during hd and outpt po iron. 8. diahrrea: pt with profuse water bowel movements - stool negative x3 for c. diff, so likely non-infectious, will reccomend outpatient symptomatic treatment, increasing fiber in diet etc . #fen-cardiac/dm #ppx-hep sc, bowel reg #)pt - consulted, either home with services vs. rehab pending their eval tomorrow am #code-full medications on admission: medications per recent discharge: aspirin 81 mg po qdaily atorvastatin 40 mg po daily paroxetine hcl 10 mg po daily gabapentin 100 mg po with hd pantoprazole 40 mg po q24h b complex-vitamin c-folic acid 1 mg capsule po daily cinacalcet 30 mg po daily senna prn docusate prn trimethoprim-sulfamethoxazole 160-800 mg po mwf metoprolol tartrate 25 mg po bid prednisone 1 mg po tid lisinopril 10 mg po daily tacrolimus 0.5 mg po daily bisacodyl 5 mg prn epogen with hd insulin nph human recomb 100 unit/ml suspension sig: 38 u qam insulin nph human recomb 100 unit/ml suspension sig: 5 u qpm ferrous sulfate 325 mg (65 mg iron) tablet po daily . discharge medications: 1. aspirin 81 mg tablet, chewable sig: one (1) tablet, chewable po daily (daily). 2. atorvastatin 40 mg tablet sig: one (1) tablet po daily (daily). 3. paroxetine hcl 10 mg tablet sig: one (1) tablet po daily (daily). 4. gabapentin 100 mg capsule sig: one (1) capsule po qhd (each hemodialysis). 5. pantoprazole 40 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po q24h (every 24 hours). 6. cinacalcet 30 mg tablet sig: one (1) tablet po daily (daily). 7. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day) as needed for constipation. 8. senna 8.6 mg tablet sig: one (1) tablet po bid (2 times a day) as needed for constipation. 9. trimethoprim-sulfamethoxazole 160-800 mg tablet sig: one (1) tablet po mwf (monday-wednesday-friday). 10. metoprolol tartrate 25 mg tablet sig: one (1) tablet po bid (2 times a day). 11. prednisone 1 mg tablet sig: one (1) tablet po tid (3 times a day). 12. lisinopril 10 mg tablet sig: one (1) tablet po daily (daily). 13. tacrolimus 0.5 mg capsule sig: one (1) capsule po daily (daily). 14. bisacodyl 5 mg tablet, delayed release (e.c.) sig: tablet, delayed release (e.c.)s po daily (daily) as needed for constipation. 15. epoetin alfa 10,000 unit/ml solution sig: as directed injection asdir (as directed): to be administered during dialysis. 16. insulin nph human recomb 100 unit/ml suspension sig: twenty five (25) units subcutaneous with breakfast. 17. insulin nph human recomb 100 unit/ml suspension sig: five (5) units subcutaneous at bedtime. 18. ferrous sulfate 325 mg (65 mg iron) tablet sig: one (1) tablet po daily (daily). 19. b complex-vitamin c-folic acid 1 mg capsule sig: one (1) cap po daily (daily). 20. cefazolin 1 gram recon soln sig: one (1) gram intravenous every monday and wednesday: dosed at hd. last dose to be . 21. cefazolin 1 gram recon soln sig: 1.5 grams intravenous every friday: dosed at hd. last dose to be . discharge disposition: home with service facility: vna discharge diagnosis: primary diagnosis: mssa bacteremia secondary diagnosis: esrd on hd, s/p cadaveric renal transplant, h/p cva, cad, dm2 discharge condition: fair. discharge instructions: you were admitted to the hospital with a diagnosis of bacteremia (staph aureus). you were treated with several different antibiotics including vancomycin, nafcillin, and most recently cefazolin. in order to give you the cefazolin you desensitization in the medical icu. after the procedure was complete you were treated with cefazolin, which will continue to be dosed at hemodialysis for the next 5 weeks. your last dose of cefazolin will be on wednesday, . . you need to have your counts monitored while on the antibiotic. these labs can be drawn during hemodialysis. at hd should check cbc, electrolytes, and lfts. please fax all lab results to infectious disease r.n. at (, md. questions regarding outpatient antibioitcs should be directed to id r.n.s at ( . you should continue to take your medications as prescribed below. you should also follow-up at the appointments listed below. if you develop any concerning symptoms including fevers, chills, chest pain, shortness of breath, abdominal pain, vomiting, or diarrhea, you should call your doctor or go to the emergency room immediately. followup instructions: provider: , md phone: date/time: 10:30 (interventional ) . provider: care id phone: date/time: 2:30 . called dr. answering service, will contact the patient regarding need for follow-up appointment in weeks by phone after monday . clinic - at 2:30 pm procedure: venous catheterization, not elsewhere classified hemodialysis immunization for allergy diagnoses: anemia in chronic kidney disease end stage renal disease pure hypercholesterolemia congestive heart failure, unspecified coronary atherosclerosis of unspecified type of vessel, native or graft polyneuropathy in diabetes methicillin susceptible staphylococcus aureus septicemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other and unspecified hyperlipidemia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits hypoxemia hyperparathyroidism, unspecified diarrhea surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation diabetes with other specified manifestations, type ii or unspecified type, uncontrolled unspecified procedure as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure complications of transplanted kidney other complications due to renal dialysis device, implant, and graft chronic diastolic heart failure background diabetic retinopathy diabetes with neurological manifestations, type ii or unspecified type, uncontrolled diabetes with ophthalmic manifestations, type ii or unspecified type, uncontrolled 

Answer: The patient is high likely exposed to